Literature DB >> 29791925

Patient-Specific Instrumentation Affects Perioperative Blood Loss in Total Knee Arthroplasty.

Davide Cucchi1,2, Alessandra Menon2,3, Beatrice Zanini4, Riccardo Compagnoni3, Paolo Ferrua5, Pietro Randelli2,3.   

Abstract

Patient-specific instrumentation (PSI) may contribute to reduced blood loss related to total knee arthroplasty (TKA). The purpose of this study was to compare the estimated hemoglobin (Hb) and red blood cell volume (RBC) losses in two groups of patients undergoing TKA with PSI and conventional instrumentation. Pre- and postoperative blood samples were collected from 22 patients randomly assigned to receive a PSI-assisted or conventional TKA. Post- to preoperative Hb difference was calculated and RBC loss was estimated according to Sehat et al. A significant difference in Hb reduction in favor of the PSI group was registered on the last day of stay (p = 0.0084) and significant treatment effect (p = 0.027) on Hb reduction after intervention was found with a regression model for longitudinal measurements. This study demonstrated that PSI leads to a significant trend in earlier Hb regain. These promising results suggest a beneficial effect of PSI in blood loss reduction. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29791925     DOI: 10.1055/s-0038-1651530

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  2 in total

1.  [Research progress on comparison of the application effects between personal specific instrumentation and computer-assisted navigation surgery in total knee arthroplasty].

Authors:  Ziyang Dong; Yang Li; Hua Tian
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-11-15

Review 2.  Patient-Specific or Conventional Instrumentations: A Meta-analysis of Randomized Controlled Trials.

Authors:  Yipeng Lin; Wufeng Cai; Baoyun Xu; Jian Li; Yuan Yang; Xuelin Pan; Weili Fu
Journal:  Biomed Res Int       Date:  2020-03-10       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.